EMHTF News and Press, Emerald Health Therapeutics From 09/04/20

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, Sept. 04, 2020 (GLOBE NEWSWIRE) -- Quinto Resources Inc. ("Quinto") (TSXV: QIT) is pleased to announce that it has entered into a property acquisition agreement dated August 12, 2020...

Emerald Health Therapeutics, Inc. (EMHTF) Q2 2020 Earnings Conference Call September 1, 2020, 10:30 AM ET Company Participants Bernie Hertel - IR Riaz Bandali - CEO Jenn Hepburn - CFO Conference Call Participants Graeme Kreindler - Eight Capital Presentation Operator...

Vancouver, British Columbia--(Newsfile Corp. - September 1, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") reported financial results for the three and six months ended June 30, 2020. Full versions of the Company's unaudited condensed interim consolidated...

Vancouver, British Columbia--(Newsfile Corp. - August 31, 2020) -  Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald")  has launched the first product in its adult-use SYNC TM Nano fast-acting cannabis spray product line. SYNC TM 15 Nano THC Fast Action Spray a...

Pure Sunfarms' Full Spectrum Vapes in 510 thread cartridges and Pure Sun CBD Oil to be available to consumers in British Columbia in coming days; Ontario and Alberta to follow Emerald will host its 2020 second quarter financial results conference call on Tuesday, September 1, 2020 at 10:30...

Vancouver, British Columbia--(Newsfile Corp. - August 21, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") today announced that it has reached an agreement with the holders of convertible debentures of the Company issued on September 10, 2019 (the "Convertib...

Emerald Health Therapeutics, Inc. (OTCQX: EMHTF) reported preliminary, unaudited financial results for the second quarter of 2020 for its 41.3%-owned joint venture, Pure Sunfarms. Gross sales fell from C$32 million ($24 million) in the second quarter of 2019 to C$19 million ($14 million) ...

Vancouver, British Columbia--(Newsfile Corp. - August 13, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has provided preliminary, unaudited financial results for the second quarter of 2020 for its 41.3%-owned joint venture, Pure Sunfarms. "Pure Sunfarms' lea...

MONTRÉAL, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Quinto Resources Inc. ("Quinto") (TSXV: QIT) and Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) have entered into a share purchase agreement dated July 30, 2020 (the "Agreement") in respect of the sale o...

The Digital Issue of the Summer 2020 MicroCap Review Magazine, The Official Magazine for the MicroCap Stock Market, can be read on www.StockNewsNow.com LOS ANGELES, CA / ACCESSWIRE / August 11, 2020 / SNN Incorporated, a global multimedia financial news and publishing company focuse...